Itraconazole methoxy triazonyl Impurity

Itraconazole methoxy triazonyl Impurity is a structurally related degradation byproduct arising from oxidative modification of the parent triazole ring in itraconazole. The compound features a methoxy-substituted triazonyl moiety at the C-5 position of the core tetrahydroisoxazole ring, with retention of the naphthalene enol ether and piperazine functionalities. This impurity results from methylation of a triazole nitrogen followed by partial oxidation, introducing a methoxy group adjacent to the positively charged triazonyl center. The compound serves as a critical HPLC reference standard for quantifying process-related impurities in itraconazole bulk drug substance.